Irmak Karaca

Dr. Irmak Karaca

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
HGHashem H Ghoraba
Hashem H Ghoraba
AAAmir Akhavanrezayat
Amir Akhavanrezayat
IKIrmak Karaca
Irmak Karaca
NYNegin Yavari
Negin Yavari
SLSherin Lajevardi
Sherin Lajevardi
QNQuan Dong Nguyen
Quan Dong Nguyen
Gene therapy has emerged as a research topic of choice in recent years. The eye in particular is one of few organs of the body for which gene therapy has received Food and Drug Administration approval, and it remains a field of great interest for gene therapy development. However, its associated immune and inflammatory reactions may render the treatment ineffective or harmful, which are of particular concern for the eyes due to their susceptibility to inflammation. The severity of immune and inflammatory reactions depends on the choice of vector and its route of administration. Furthermore, most preclinical and clinical studies have shown that the dose of vectors is correlated with the degree of humoral response and ocular inflammation. The route of administration directly impacts the degree of immune and inflammatory reaction. Subretinal delivery produces a weaker humoral response than the intravitreal route. However, some studies have demonstrated that the subretinal delivery induces a stronger inflammatory reaction. On the other hand, several instances of vision loss due to severe late onset intraocular inflammation were reported in a clinical trial involving intravitreal delivery of viral vectors. When compared with the intravitreal route, suprachoroidal gene delivery has been shown to produce weaker humoral response. However, unlike the subretinal space, the suprachoroidal space is not known to have immune privilege status. Inflammatory reactions following ocular gene therapy are typically mild and most clinical and preclinical studies have shown that they can be controlled with topical, local or systemic steroids. However, severe inflammatory responses may occur and require aggressive management to avoid permanent vision loss. Further investigations are required to elucidate and expand our knowledge of inflammatory reactions, and their optimal management, following ocular gene therapy.

1 October 2019 in The Ocular Surface
Verified
Journal Article
Closed access
IKIrmak Karaca
Irmak Karaca
AYAyse Yagci
Ayse Yagci
MPMelis Palamar
Melis Palamar
MTMehmet Sezai Tasbakan
Mehmet Sezai Tasbakan
OBOzen K. Basoglu
Ozen K. Basoglu

1 September 2021 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
WMWataru Matsumiya
Wataru Matsumiya
IKIrmak Karaca
Irmak Karaca
HGHashem Ghoraba
Hashem Ghoraba
AAAmir Akhavanrezayat
Amir Akhavanrezayat
AMAzadeh Mobasserian
Azadeh Mobasserian
QNQuan Dong Nguyen
Quan Dong Nguyen
To describe structural changes in corneal epithelium using anterior segment optical coherence tomography (AS-OCT) in two relapsed and refractory multiple myeloma (RRMM) patients with bilateral belantamab-associated superficial keratopathy (BASK). A 56-year-old male who was diagnosed with RRMM and initiated on belantamab mafodotin, presented on day 42 (three weeks after the second infusion) with decreased pinhole visual acuity from 20/20 and 20/25 to 20/70 and 20/50 in the right eye and left eye, respectively. Slit-lamp examination revealed moderate superficial keratopathy with microcystic-like epithelial changes (MECs) in the paracentral cornea in both eyes. AS-OCT demonstrated increased bilateral heterogeneous signal intensity and hyperreflective lesions as well as increased thickness in the paracentral corneal epithelium with uninvolved central cornea. Given bilateral MECs, the third infusion was withheld, and then given on day 62 after five weeks of drug-free interval. Although MECs had improved on day 82, pinhole visual acuity remained at 20/50 and 20/40 in the right eye and the left eye. AS-OCT showed that hyperreflective lesions mostly resolved and corneal epithelial thickness returned to baseline, despite a slightly increased persisting heterogeneous signal intensity in the peripheral corneal epithelium in both eyes. A 77-year-old male with RRMM was started on belantamab mafodotin infusions. His pinhole visual acuity decreased from 20/40 and 20/30 at baseline to 20/60 and 20/40 on day 41 (three weeks after the second infusion) in the right eye and left eye, respectively. Slit-lamp examination showed diffuse, moderate MECs in both eyes, which was more severe in the peripheral cornea. AS-OCT demonstrated increased bilateral heterogeneous signal intensity and hyperreflective lesions in the corneal epithelium, which are more severe in the right eye along with increased corneal epithelial thickness. Therefore, belantamab mafodotin was withheld. AS-OCT objectively demonstrated structural changes such as signal intensity and thickness alterations with hyperreflective lesions in the corneal epithelium related to BASK. AS-OCT might be useful for clinicians to monitor ocular surface adverse events in RRMM patients receiving belantamab mafodotin and to adjust therapeutic plans for the patients.

3 May 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
IKIrmak Karaca
Irmak Karaca
SYSuzan Güven Yılmaz
Suzan Güven Yılmaz
FAFiliz Afrashi
Filiz Afrashi
SNSerhad Nalçacı
Serhad Nalçacı

21 December 2022 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
GUGunay Uludag
Gunay Uludag
IKIrmak Karaca
Irmak Karaca
AAAmir Akhavanrezayat
Amir Akhavanrezayat
CYCigdem Yasar
Cigdem Yasar
WMWataru Matsumiya
Wataru Matsumiya
QNQuan Dong Nguyen
Quan Dong Nguyen
To determine the outcomes of intravenous (IV) tocilizumab (TCZ) in patients with non-infectious uveitis who failed with conventional immunomodulatory and anti-TNFα therapies.Records of seven patien...

28 November 2022 in Eye
Verified
Journal Article
Closed access
PDF file
IKIrmak Karaca
Irmak Karaca
GUGunay Uludag
Gunay Uludag
WMWataru Matsumiya
Wataru Matsumiya
JRJonathan Regenold
Jonathan Regenold
COChristopher Or
Christopher Or
QNQuan Dong Nguyen
Quan Dong Nguyen